Literature DB >> 11397643

Nuclear receptors, coactivators and chromatin: new approaches, new insights.

K C Lee1, W Lee Kraus.   

Abstract

The actions of lipophilic hormones, including steroids, retinoids, thyroid hormone and vitamin D(3), are mediated through a conserved superfamily of nuclear receptor proteins that function as ligand-regulated, DNA-binding transcriptional activators in the chromatin environment of the nucleus. The ligand-dependent transcriptional activity of nuclear receptors is enhanced by various cofactors that remodel chromatin, acetylate nucleosomal histones and contact the basal transcriptional machinery. The current challenge is to understand the mechanistic details of how interactions among these factors enhance transcription of hormone-regulated genes assembled into chromatin. Current biochemical and cell-based methods are providing some important clues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397643     DOI: 10.1016/s1043-2760(01)00392-7

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  21 in total

1.  Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.

Authors:  Nima Alamdari; Ira J Smith; Zaira Aversa; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

Review 2.  Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes.

Authors:  James H Segars; Paul H Driggers
Journal:  Trends Endocrinol Metab       Date:  2002-10       Impact factor: 12.015

3.  Histone H1 represses estrogen receptor alpha transcriptional activity by selectively inhibiting receptor-mediated transcription initiation.

Authors:  Edwin Cheung; Alla S Zarifyan; W Lee Kraus
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Biochemical characterization of androgen receptor-interacting protein 4.

Authors:  Andrii Domanskyi; Katja T Virtanen; Jorma J Palvimo; Olli A Jänne
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

5.  PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.

Authors:  Kang Le; Ruifang Li; Suowen Xu; Xiaoqian Wu; Heqing Huang; Yingxia Bao; Yi Cai; Tian Lan; Joel Moss; Cuixian Li; Jian Zou; Xiaoyan Shen; Peiqing Liu
Journal:  Arch Biochem Biophys       Date:  2011-12-16       Impact factor: 4.013

6.  Analysis of chromatin dynamics during glucocorticoid receptor activation.

Authors:  Craig J Burd; James M Ward; Valerie J Crusselle-Davis; Grace E Kissling; Dhiral Phadke; Ruchir R Shah; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2012-03-26       Impact factor: 4.272

Review 7.  Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.

Authors:  E Kassi; P Moutsatsou
Journal:  J Biomed Biotechnol       Date:  2010-06-10

8.  Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor.

Authors:  Mi Young Kim; Eileen M Woo; Yee Ting Esther Chong; Daria R Homenko; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2006-02-23

9.  Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor.

Authors:  Laura P Zanello; Anthony W Norman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

10.  Chronic treatment with the peroxisome proliferator-activated receptor alpha agonist Wy-14,643 attenuates myocardial respiratory capacity and contractile function.

Authors:  Makhosazane Zungu; Martin E Young; William C Stanley; M Faadiel Essop
Journal:  Mol Cell Biochem       Date:  2009-04-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.